Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

GSK presents phase II data for linerixibat, a potential oral treatment for primary biliary cirrhosis

Nov. 23, 2020

AVO-101: promising results for weight loss and NASH reduction

Nov. 20, 2020

Synergy seen for DA-1241 with DPP4 inhibitor for the treatment of NASH

Nov. 19, 2020

First-in-human phase Ib data presented for CM-101 in patients with NAFLD

Nov. 18, 2020

OSE Immunotherapeutics' agonist monoclonal antibody OSE-230 designed to resolve inflammation

Nov. 16, 2020

Shanghai Institute of Materia Medica discloses NR1H4 agonists

Nov. 12, 2020

Immuron reports new data on vaccine targeting Campylobacter and ETEC

Nov. 10, 2020

Seres Therapeutics initiates phase Ib study of SER-301 in ulcerative colitis

Nov. 9, 2020

Microbiome confounders research complicates control groups

Nov. 5, 2020

BiomX begins first-in-human study of BX-002 phage therapy for IBD

Nov. 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...